title: Vanadate inhibition of fungal PhyA and bacterial AppA2 histidine acid phosphatases.
abstract: The fungal PhyA protein, which was first identified as an acid optimum phosphomonoesterase (EC 3.1.3.8), could also serve as a vanadate haloperoxidase (EC 1.11.1.10) provided the acid phosphatase activity is shut down by vanadate. To understand how vanadate inhibits both phytate and pNPP degrading activities of fungal PhyA phytase and bacterial AppA2 phytase, kinetic experiments were performed in the presence and absence of orthovanadate and metavanadate under various acidic pHs. Orthovanadate was found to be a potent inhibitor at pH 2.5 to 3.0. A 50% activity of fungal phytase was inhibited at 0.56 μM by orthovanadate. However, metavanadate preferentially inhibited the bacterial AppA2 phytase (50% inhibition at 8 μM) over the fungal phytase (50% inhibition at 40 μM). While in bacterial phytase the K(m) was not affected by ortho- or metavanadate, the V(max) was reduced. In fungal phytase, both the K(m) and V(max) was lowered. The vanadate exists as an anion at pH 3.0 and possibly binds to the active center of phytases that has a cluster of positively charged Arg, Lys, and His residues below the enzymes' isoelectric point (pI). The active site fold of haloperoxidase was shown to be very similar to fungal phytase. The vanadate anions binding to cationic residues in the active site at acidic pH thus serve as a molecular switch to turn off phytase activity while turning on the haloperoxidase activity. The fungal PhyA phytase's active site housing two distinct reactive centers, one for phosphomonoesterase and the other for haloperoxidase, is a unique example of how one protein could catalyze two dissimilar reactions controlled by vanadate.
authors.affiliation: Southern Regional Research Center, ARS, USDA, New Orleans, Louisiana 70124, United States. abul.ullah@ars.usda.gov
authors.forename: Abul H
authors.initials: AH
authors.lastname: Ullah
authors.forename: Kandan
authors.initials: K
authors.lastname: Sethumadhavan
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Mullaney
mesh_terms: D010832:6-Phytase / Q000037:antagonists & inhibitors*; D000135:Acid Phosphatase / Q000037:antagonists & inhibitors*; D001234:Aspergillus niger / Q000201:enzymology; D004338:Drug Combinations; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D029968:Escherichia coli Proteins / Q000037:antagonists & inhibitors*; D005656:Fungal Proteins / Q000037:antagonists & inhibitors*; D007700:Kinetics; D009097:Multienzyme Complexes / Q000037:antagonists & inhibitors*; D009821:Oils; D010636:Phenols; D011994:Recombinant Proteins; D014638:Vanadates / Q000494:pharmacology*
chemical_list: D004338:Drug Combinations; D004791:Enzyme Inhibitors; D029968:Escherichia coli Proteins; D005656:Fungal Proteins; D009097:Multienzyme Complexes; D009821:Oils; C027222:P & S Liquid; D010636:Phenols; D011994:Recombinant Proteins; D014638:Vanadates; D000135:Acid Phosphatase; D010832:6-Phytase; C118716:AppA2 protein, E coli